Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

796
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
796
Neural Regulation01:37

Neural Regulation

40.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

422
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
422

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Dynamics of Polyglutamine-Expanded ATXN3 in Biofluids of Spinocerebellar Ataxia Type 3.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Discovery of a mutation-containing circRNA in polyglutamine disease through systematic analysis of RNAs with CAG repeats.

RNA biology·2026
Same author

Impaired emotional regulation in the elderly men following female partner loss.

The Behavioral and brain sciences·2026
Same author

Objective Dynamic Assessment of Facial Movement Asymmetry in Children Using a Marker-Based Video Method.

Journal of clinical medicine·2026
Same author

The underrated value of non-motor symptoms of Parkinson's disease in making diagnostic and treatment decisions.

Neurologia i neurochirurgia polska·2026
Same author

Restless legs syndrome treatment - gabapentinoids or dopamine agonists?

Neurologia i neurochirurgia polska·2026

Related Experiment Video

Updated: Oct 2, 2025

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.0K

Computer Aided Written Character Feature Extraction in Progressive Supranuclear Palsy and Parkinson's Disease.

Paula Stępień1, Jacek Kawa1, Emilia J Sitek2,3

  • 1Faculty of Biomedical Engineering, Silesian University of Technology, 41-800 Zabrze, Poland.

Sensors (Basel, Switzerland)
|February 26, 2022
PubMed
Summary

Luria's Alternating Series Test (LAST) effectively distinguishes Parkinson's disease (PD) and progressive supranuclear palsy (PSP) patients from healthy seniors. Automated analysis of drawing patterns identified key features for differentiating these neurodegenerative conditions.

Keywords:
baseline estimationcharacter recognitioncomputer aided diagnosisneurodegenerative diseasespattern analysiswriting analysis

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.8K

Related Experiment Videos

Last Updated: Oct 2, 2025

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.0K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.8K

Area of Science:

  • Neuroscience
  • Neurology
  • Cognitive Science

Background:

  • Parkinson's disease (PD) and progressive supranuclear palsy (PSP) are neurodegenerative disorders impacting cognitive function.
  • Prefrontal and frontostriatal dysfunction, indicated by graphomotor and perseverative issues, is common in PD and PSP.
  • The Luria's Alternating Series Test (LAST) assesses these cognitive-motor deficits.

Purpose of the Study:

  • To evaluate the utility of the Luria's Alternating Series Test (LAST) in differentiating PD and PSP.
  • To develop an automated method for analyzing LAST performance.
  • To identify novel features from LAST for improved diagnostic accuracy.

Main Methods:

  • Neuropsychological assessment including the paper-and-pencil LAST was administered to 51 PD patients, 22 PSP patients, and 32 healthy seniors.
  • Scanned LAST drawings were preprocessed for automatic character segmentation and shape recognition (rectangles, triangles).
  • Seventy-one standard and novel features were extracted from the series, images, and signals, then normalized.

Main Results:

  • Fifty-one out of 71 extracted features significantly differentiated the three groups (p < 0.05).
  • An automated classifier achieved 70.5% accuracy in distinguishing between PD, PSP, and healthy control groups.
  • The LAST, when analyzed with novel features, shows promise in identifying specific neurodegenerative patterns.

Conclusions:

  • Automated analysis of the Luria's Alternating Series Test (LAST) provides valuable quantitative data for differentiating neurodegenerative movement disorders.
  • The LAST is a sensitive tool for detecting cognitive-motor deficits associated with Parkinson's disease and progressive supranuclear palsy.
  • This approach offers a potential objective method to aid in the clinical assessment and differential diagnosis of PD and PSP.